'India began drug discovery before China, but China has moved years ahead'

Business Standard 1 h India

India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy

Aggregated from the leading newsrooms of the country. Every story links to its original source.